SVTR 硅谷科技评论SVTR
← Database
ApplicationsLife Sciences
Total funding $14M📍 IsraelFounded 2018

About

Founded in 2018 in Tel Aviv, Nucleai applies AI to analyze pathology images for medical research and clinical diagnostics.

★ SVTR RatingSVTR has evaluated this company

Full tier & rationale — an SVTR Intelligence benefit

Capital graph

CompanyInvestorFounders / teamCo-investment (thicker arc = more shared deals, ×N marks the count)Bigger circle = stronger signal (activity / coverage / interest) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile

Founders / core team

Investors

Funding history

Comparable companies· by market

MostSimilar business · Same sector: Life Sciences · Similar total funding

Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.

Investors that may fit

General Catalyst

39 Life Sciences deals in the last 24 months · 1 in 以色列

Request intro →

Insight Partners

14 Life Sciences deals in the last 24 months · 1 in 以色列

Request intro →

OrbiMed Advisors

9 Life Sciences deals in the last 24 months · 1 in 以色列

Request intro →

Connecticut Innovations

6 Life Sciences deals in the last 24 months · 2 in 以色列

Request intro →

NVentures

6 Life Sciences deals in the last 24 months · 1 in 以色列

Request intro →

Entrée Capital

5 Life Sciences deals in the last 24 months · 1 in 以色列

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach Nucleai — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal